XML 64 R42.htm IDEA: XBRL DOCUMENT

Equity-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Equity compensation expense is included in operating expenses and in selling, general and administrative expenses in the accompanying consolidated statements of operations as follows:


	For the Year Ended December 31,
	2023		2022		2021
	(In thousands)
Equity compensation expense included in operating expenses	$	1,947	$	4,427	$	9,578
Equity compensation expense included in selling, general and administrative expenses		15,085		13,731		30,144
Total equity compensation expense	$	17,032	$	18,158	$	39,722

Schedule of Time-Vesting and Performance Vesting Restricted Share Awards

The activity related to the Company’s time-vesting and performance-vesting restricted awards during the year ended December 31, 2023 was as follows:


						Performance-Vesting Restricted Awards
	Time-Vesting Restricted Awards					Bonus Performance Restricted Awards					Long-Term Incentive Performance Restricted Awards
	Shares/Units			Weighted Average Grant Date Fair Value per Award		Shares/Units			Weighted Average Grant Date Fair Value per Award		Shares/Units			Weighted Average Grant Date Fair Value per Award
Outstanding at December 31, 2022		533,160		$	44.90		99,050		$	65.16		859,483		$	39.19
Granted		248,517		$	59.31		142,460		$	51.42		263,001		$	56.25
Vested		(140,418	)	$	46.27		(22,299	)	$	65.17		(209,957	)	$	29.08
Forfeited		(74,107	)	$	49.50		(84,214	)	$	64.46		(153,071	)	$	46.55
Outstanding at December 31, 2023		567,152		$	50.28		134,997		$	51.09		759,456		$	46.41

Schedule of Activity Related to Stock Option Awards

The total intrinsic value of stock options exercised during the years ended December 31, 2023, 2022 and 2021 was approximately $3.1 million, $4.2 million and $9.5 million, respectively. The activity related to the Company’s stock option awards during the year ended December 31, 2023 was as follows:


	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in years)		Aggregate Intrinsic Value (in thousands)
Outstanding at December 31, 2022		513,712		$	39.75
Granted		129,635		$	56.90
Forfeited		(97,538	)	$	49.19
Expired		(6,711	)	$	42.90
Exercised		(110,584	)	$	26.58
Outstanding at December 31, 2023		428,514		$	46.14		6.90	$	4,290
Exercisable at December 31, 2023		196,309		$	33.46		4.82	$	4,115

Schedule of Stock Options Valuation Assumptions

The weighted average grant date fair value of stock options granted during the year ended December 31, 2023 was $34.48. Key weighted-average assumptions utilized in the Black-Scholes Option Pricing Model for stock options granted during the year ended December 31, 2023 were:


Risk-free interest rate	3.66	%
Expected volatility	62.12	%
Expected dividend yield	0.00	%
Expected life (years) (a)	6.12

(a)

The expected life was estimated using the simplified method, as the Company does not have sufficient historical exercise data due to the limited period of time its common stock has been publicly traded.